President Yoweri Museveni will commission a $50 million cassava starch facility in Namasagali that marks the first phase of Dei Biopharma's effort to reduce Uganda's reliance on imported pharmaceutical ingredients. The plant, which will process approximately 500 metric tons of cassava daily from more than 3,000 registered farmers across Busoga, Teso, Lango and Bukedi, aims to produce glucose, maltose, fructose and pharmaceutical-grade starch for export once it secures FDA certification. Company founder Matthias Magoola said nearly all starch and excipients used in tablet and capsule manufacturing are currently imported, making local production costly and uncompetitive.
The facility sits within a 5,000-acre agro-industrial zone that...